Nick Thornton
Chairman
Nick joined the Symbio Board in December 2023 following his appointment as Operating Partner at ARCHIMED. With over two decades of experience in the CRO and life sciences industries, Nick brings extensive investment, leadership and strategic expertise to Symbio.
Nick previously served as Executive Chairman of Chiltern, a leading mid-tier CRO and was Chairman of Avania, the prominent med-tech CRO. He was also a Director of Greenleaf Health, the specialist FDA advisory firm. In addition, Nick holds Directorships in selected other industries, allowing him to combine deep sector knowledge with broad global experience.
Nick graduated LLB, MBA from the University of Auckland, New Zealand.